` Comparison: PFE, NOVO B - Alpha Spread

PFE
vs
NOVO B

Over the past 12 months, PFE has significantly outperformed NOVO B, delivering a return of -18% compared to the NOVO B's 49% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
PFE
NOVO B
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

PFE Intrinsic Value
28.61 USD
Undervaluation 13%
Intrinsic Value
Price
NOVO B Intrinsic Value
644.98 DKK
Undervaluation 30%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Pfizer Inc
NYSE:PFE
24.79 USD
Novo Nordisk A/S
CSE:NOVO B
452.1 DKK
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
PFE, NOVO B

PFE
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Pfizer Inc
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
PFE, NOVO B

PFE
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Pfizer Inc
NYSE:PFE
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

PFE
74.6%
NOVO B
84.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Pfizer Inc
Novo Nordisk A/S

Operating Margin

PFE
27.1%
NOVO B
44.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Pfizer Inc
Novo Nordisk A/S

Net Margin

PFE
12.6%
NOVO B
34.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Pfizer Inc
Novo Nordisk A/S

FCF Margin

PFE
18%
NOVO B
24.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Pfizer Inc
Novo Nordisk A/S

ROE

PFE
8.8%
NOVO B
88.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Pfizer Inc
Novo Nordisk A/S

ROA

PFE
3.6%
NOVO B
26.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Pfizer Inc
Novo Nordisk A/S

ROIC

PFE
9.2%
NOVO B
30.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Pfizer Inc
Novo Nordisk A/S

ROCE

PFE
9.7%
NOVO B
70%
LTM 3Y Avg 5Y Avg 10Y Avg
Pfizer Inc
Novo Nordisk A/S

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
PFE, NOVO B

Loading

Performance Gap
PFE, NOVO B

Loading
PFE
NOVO B
Difference
www.alphaspread.com

Performance By Year
PFE, NOVO B

Loading
PFE
NOVO B
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare PFE to other stocks
Unlock Full Access to Alpha Spread
Create Free Account